drugset / Trial / NCT03417401
Surgical Stabilizer Assisted RVC With rtPA for CRVO
NaSingle-groupOpen-labelTreatment
Summary
This phase Ib study investigates the safety and efficacy of performing a retinal vein cannulation with recombinant tissue Plasminogen Activator infusion into a retinal vein with the help of an updated dedicated surgical stabiliser for the treatment of central retinal vein occlusion.
Timeline
- Start
- 2018-10-16
- Primary completion
- 2021-12-10
- Completion
- 2021-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alteplase | Protein / enzyme biologic | 1 mg | Intravenous |